Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Mesenchymal Stem/Stromal Cells
      • Serum
      • Xeno-free
      • cGMP CliniControl™
    • Cell Culture Media & Supplements
      • Serum
      • Xeno-free
      • cGMP CliniControl™
    • Exosomes/Extracellular Vesicles
      • Media & Supplements
      • cGMP CliniControl™ Production Media
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor Screening Kits
      • hMSC Tissue Screening Kits
      • Bioreactor Kits & Bundles
    • cGMP CliniControl™ Products
      • Human Mesenchymal Stem/Stromal Cells
      • Cell Culture Media & Supplements
      • Exosome/Extracellular Vesicle Production Media
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

News

Why Cell Manufacturing Matters: How Bioprocess Innovations Have Laid the Foundation for a Cell-Based Products Revolution

BioProcess International October 20, 2022

Maryland Stem Cell Research Commission Announces Over $7 Million in Awards to Accelerate Cures

Maryland Stem Cell Research Fund May 16, 2022

ISCT 2022 Interview with Tim Kelly: RoosterBio & ShiftBio Partner to Harness the Power of MSCs & Exosomes

The Science Advisory Board May 10, 2022

Cell & Gene Therapy Pioneer Robert Preti Joins RoosterBio Board of Directors

PRWeb April 4, 2022

Portfolio Company RoosterBio Highlighted in Dynamk’s Recent Annual General Meeting

Dynamk Capital November 1, 2021

RoosterBio Appoints Timothy M. Kelly as CEO

I95 BUSINESS October 28, 2021

Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis

Pharma’s Almanac September 29, 2021

RoosterBio Releases RoosterGEM™, Cell and Gene Therapy’s First Complete Transduction Medium

BioInformant May 21, 2021

Women Leaders in Life Sciences: Meet Six Powerful Leaders in the Field

I95 BUSINESS April 13, 2021

Rooster Bio and Sartorius Team to Streamline hMSC Production

BioProcess International January 22, 2021
1 2 3 Next

Sidebar Navigation

  • News
  • Events
  • Press Releases
  • Media Kit

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Mesenchymal Stem/Stromal Cells
    • Cell Culture Media & Supplements
    • Exosomes/Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2023 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Wood Street, Inc.

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email